EAACI Congress 2024 Back
Sophia Karagiannis
United Kingdom
B cell immunologist with academic and biotechnology experience, focused on developing antibodies and antibody-drug conjugates for cancer therapy and dissecting humoral immunity in tumours. First to design and translate IgE therapies for cancer to clinical testing and founder of Epsilogen Ltd.
Sessions
Saturday 1 Jun
15:00 -
16:30
TSY5 Clonal Mast cell disorder : diseases who need a multidisciplinary approch Thematic Symposia Barcelona , Channel Barcelona
TSY5 Clonal Mast cell disorder : diseases who need a multidisciplinary approch Thematic Symposia Barcelona , Channel Barcelona